Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
01/2012
01/17/2012US8097611 Sulfonyl-derivatives as novel or histone deacetylase
01/17/2012US8097238 Cell targeting conjugates
01/17/2012CA2559611C Pyrrolidine compounds
01/17/2012CA2494846C Arylamides
01/17/2012CA2473986C Indazole compounds useful as protein kinase inhibitors
01/17/2012CA2385456C 9-(piperazinylalkyl) carbazoles as bax-modulators
01/12/2012WO2012006474A2 Compounds and methods for inhibiting phosphate transport
01/12/2012WO2012006473A1 Compounds and methods for inhibiting phosphate transport
01/12/2012WO2012006419A2 Pro-neurogenic compounds
01/12/2012WO2012005363A1 Organic electroluminescent element
01/12/2012WO2012005299A1 Ros tyrosine kinase inhibitor
01/12/2012WO2012005172A1 Organic electroluminescent element
01/12/2012WO2012004811A1 Process for the preparation of 5-substsituted indole derivative
01/12/2012WO2012004743A1 Benzenesulfonamides useful as sodium channel inhibitors
01/12/2012WO2012004604A1 Tetrazole compounds as calcium channel blockers
01/12/2012WO2012004326A1 Pesticidal pyrroline derivatives
01/12/2012WO2012004212A1 Heterocyclic antiviral compounds
01/12/2012WO2012003784A1 Pyrazine derivatives,process for manufacture and use thereof
01/12/2012WO2012003712A1 1,2-bis-(4,7-dimethyl-1,4,7-triazacyclonon-1-yl)-ethane and intermediate thereof
01/12/2012WO2012003599A1 Methods for the synthesis of bis (triazacyclononane) ligands
01/12/2012US20120010405 Optically active 3-amino-2,5-dioxopyrrolidine-3-carboxylate, process for production of the compound, and use of the compound
01/12/2012US20120010283 Modulation of anxiety through blockade of anandamide hydrolysis
01/12/2012US20120010250 Anthranilamide derivatives as pesticides
01/12/2012US20120010241 Hsp90 inhibiting indazole derivatives, compositions containing same and use thereof
01/12/2012US20120010235 N-substituted pyrrolidines
01/12/2012US20120010222 Gyrase Inhibitors and Uses Thereof
01/12/2012US20120010212 Methyl-pyrrolidine ether derivatives
01/12/2012US20120010204 Phthalazinone Derivatives
01/12/2012US20120010200 Biaryl Heterocyclic Compounds And Methods Of Making And Using The Same
01/12/2012US20120010195 Imidazole derivatives
01/12/2012US20120010185 New pyridone derivates with mch antagonistic activity and medicaments comprising these compounds
01/12/2012US20120010184 Therapeutic Uses of Compounds Which Selectively Modulate The CB2 Receptor
01/12/2012US20120010182 Chemical Compounds
01/12/2012US20120010181 Compounds for the treatment of inflammatory disorders
01/12/2012US20120009151 Triazines And Related Compounds Having Antiviral Activity, Compositions And Methods Thereof
01/12/2012US20120009144 Heterocyclic antiviral compounds
01/12/2012US20120009142 Methods for treating hepatitis c
01/12/2012US20120009141 Functionalized pyrrolidines and use thereof as iap inhibitors
01/12/2012US20120009121 Psma-targeting compounds and uses thereof
01/12/2012US20120008228 Magnetic recording media and magnetic recording system
01/12/2012CA2804593A1 Biphenyloxybenzensulphonamide derivatives
01/12/2012CA2804475A1 1,2-bis-(4,7-dimethyl-1,4,7-triazacyclonon-1-yl)-ethane and intermediate thereof
01/12/2012CA2801670A1 Heterocyclic antiviral compounds
01/11/2012EP2404904A1 5-lipoxygenase-activating protein (FLAP) inhibitors
01/11/2012EP2404902A1 Piperidine and pyrrolidine derivatives having npy y5 receptor antagonism
01/11/2012EP2404901A1 1,2-Disubstituted 4-benzylamino-pyrrolidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis
01/11/2012EP2403852A1 3h-imidazo [4, 5 -c]pyridine- 6 -carboxamides as anti- inflammatory agents
01/11/2012EP2403846A1 Inhibitors of bruton's tyrosine kinase
01/11/2012EP2403839A2 Neurotrophin mimetics and uses thereof
01/11/2012EP2403837A1 3-arylquinazolin-4-one compounds for combating invertebrate pests
01/11/2012EP2403835A1 Novel phenyl imidazoles and phenyl triazoles as gamma-secretase modulators
01/11/2012EP2403834A1 Fungicidal pyrazoles
01/11/2012EP2403832A1 N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators
01/11/2012EP2173735B1 Imidazole derivatives as ccr2 receptor antagonists
01/11/2012EP2150534B1 Isoquinolinone derivatives as nk3 antagonists
01/11/2012EP1802591B1 Quinazoline derivatives
01/11/2012EP1763518B1 Substituted 2-alkyl quinazolinone derivatives as parp inhibitors
01/11/2012EP1458687B1 Pyrimidine compounds as interleukin-12 (il-12) inhibitors
01/11/2012EP1334968B1 Process for producing substituted aniline compound
01/11/2012CN102317328A Polymer compound and organic electroluminescent device using the same
01/11/2012CN102317290A STAT3 inhibitors and therapeutic methods using the same
01/11/2012CN102317284A Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases
01/11/2012CN102317283A Novel cc-1065 analogs and their conjugates
01/11/2012CN102317282A Hetero ring derivative
01/11/2012CN102317281A Pyrimidinones as casein kinase ii (CK2) modulators
01/11/2012CN102317278A 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2
01/11/2012CN102317269A Novel amino azaheterocyclic carboxamides
01/11/2012CN102317268A 2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors
01/11/2012CN102317266A 6-phenylpyrimidinones as PIM modulators
01/11/2012CN102317265A 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders
01/11/2012CN102311426A Preparation method of olmesartan intermediate
01/11/2012CN102311399A Triazole alcohol antifungal compounds with nitrogen-containing side chains, preparation method thereof and application thereof
01/11/2012CN102311387A 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
01/11/2012CN101824002B Water soluble triazole compound and synthesis method thereof
01/11/2012CN101370786B Substituted imidazoles and their use as pesticides
01/11/2012CN101312725B Hexahydro cyclooctyl pyrazole cannabinoid modulators
01/10/2012US8093404 Macrocyclic dyes having aryl moieties
01/10/2012US8093385 Leukotriene B4 inhibitors
01/10/2012US8093380 Compounds with the bicyclo[4.2.1]nonane system for the treatment of Flaviviridae infections
01/10/2012US8093379 Macrocyclic serine protease inhibitors
01/10/2012US8093251 Nitrogen-containing heterocyclic compounds and thrombopoietin receptor activators
01/10/2012US8093246 potent deoxycytidine kinase inhibitors; O-linked pyrimidin-4-amine-based compounds
01/10/2012US8093245 Anticancer agents; potent Deoxycytidine kinase inhibitors; inhibit thymidine kinase; inhibit uridine kinase; N-[3-(4-amino-5-fluoro-2-oxo-2H-pyrimidin-1-yl)-cyclopentyl]-3-bromo-benzenesulfonamide
01/10/2012US8093244 Heteroaryl urea derivatives useful for inhibiting CHK1
01/10/2012US8093239 Imidazopyridine kinase inhibitors
01/10/2012CA2507184C 1, 2, 3- triazole amide derivatives as cytokine inhibitors
01/10/2012CA2486183C Protein kinase inhibitors
01/10/2012CA2436665C Nucleic acid derivatives
01/05/2012WO2012003189A1 Compositions and methods for modulating the wnt signaling pathway
01/05/2012WO2012002527A1 HETEROCYCLIC COMPOUND, AND p27 KIP1 DEGRADATION INHIBITOR
01/05/2012WO2012002502A1 Dihydropyrimidinone derivative and pharmaceutical use thereof
01/05/2012WO2012002328A1 Blood hdl level increasing agent or anti-arteriosclerotic agent
01/05/2012WO2012002096A1 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides
01/05/2012WO2012001986A1 Compound with carbazole ring structure and organic electroluminescent element
01/05/2012WO2012000933A1 3-amino-5,6-dihydro-1h-pyrazin-2-one derivatives useful for the treatement of alzheimer's disease and other forms of dementia
01/05/2012WO2012000519A1 Aryl- and heteroarylamid derivatives as pde10a enzyme inhibitor
01/05/2012WO2012000356A1 Quinazoline compounds
01/05/2012WO2012000304A1 Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof
01/05/2012WO2012000182A1 Quinazoline compounds
01/05/2012WO2011112428A3 Arylvinylazacycloalkane compounds for constipation